• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

围产期给予地西泮可预防精神分裂症 MAM 发育障碍模型中多巴胺系统反应过度的出现。

Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia.

机构信息

Department of Neuroscience, University of Pittsburgh, Pittsburgh, PA 15260, USA.

出版信息

Neuropsychopharmacology. 2013 Sep;38(10):1881-8. doi: 10.1038/npp.2013.101. Epub 2013 Apr 23.

DOI:10.1038/npp.2013.101
PMID:23612434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3746684/
Abstract

Schizophrenia is believed to arise from an interaction of genetic predisposition and adverse environmental factors, with stress being a primary variable. We propose that alleviating anxiety produced in response to stress during a sensitive developmental period may circumvent the dopamine (DA) system alterations that may correspond to psychosis in adults. This was tested in a developmental rat model of schizophrenia based on prenatal administration of the mitotoxin methyl azoxymethanol acetate (MAM). MAM administration leads to a hyperdopaminergic state consisting of an increase in the number of DA neurons firing spontaneously, which correlates with an increased behavioral response to amphetamine. MAM-treated rats exhibited a heightened level of anxiety during adolescence. Peripubertal administration of the antianxiety agent diazepam was found to prevent the increase in DA neuron activity and blunt the behavioral hyperresponsivity to amphetamine in these rats. These data suggest that the pathophysiological factors leading to the onset of psychosis in early adulthood may be circumvented by controlling the response to stress during the peripubertal period.

摘要

精神分裂症被认为是遗传易感性和不利环境因素相互作用的结果,其中压力是一个主要变量。我们提出,在敏感的发育阶段缓解应激引起的焦虑,可能会避免与成人精神病相对应的多巴胺(DA)系统改变。这在基于产前给予促有丝分裂原甲基偶氮甲烷乙酸盐(MAM)的精神分裂症发育大鼠模型中进行了测试。MAM 给药导致多巴胺能亢进状态,表现为自发放电的 DA 神经元数量增加,这与对安非他命的行为反应增加相关。MAM 处理的大鼠在青春期表现出更高水平的焦虑。研究发现,青春期前给予抗焦虑药地西泮可预防 DA 神经元活动的增加,并减轻这些大鼠对安非他命的行为高反应性。这些数据表明,通过控制青春期期间对压力的反应,可能会避免导致成年早期精神病发作的病理生理因素。

相似文献

1
Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia.围产期给予地西泮可预防精神分裂症 MAM 发育障碍模型中多巴胺系统反应过度的出现。
Neuropsychopharmacology. 2013 Sep;38(10):1881-8. doi: 10.1038/npp.2013.101. Epub 2013 Apr 23.
2
Amygdala Hyperactivity in MAM Model of Schizophrenia is Normalized by Peripubertal Diazepam Administration.青春期前给予地西泮可使精神分裂症MAM模型中的杏仁核过度活跃恢复正常。
Neuropsychopharmacology. 2016 Sep;41(10):2455-62. doi: 10.1038/npp.2016.42. Epub 2016 Mar 22.
3
Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia.青春期给予大麻素对精神分裂症发育障碍模型中注意力转换和多巴胺能反应过度的影响。
Int J Neuropsychopharmacol. 2014 Dec 13;18(2):pyu018. doi: 10.1093/ijnp/pyu018.
4
Impaired contextual fear-conditioning in MAM rodent model of schizophrenia.精神分裂症 MAM 啮齿动物模型中的情景恐惧条件反射受损。
Schizophr Res. 2018 May;195:343-352. doi: 10.1016/j.schres.2017.08.064. Epub 2017 Sep 18.
5
Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia.在醋酸甲基氧化偶氮甲醇所致精神分裂症模型中,先前的抗精神病药物治疗会阻碍对新型抗精神病药物的反应。
Schizophr Bull. 2014 Mar;40(2):341-50. doi: 10.1093/schbul/sbt236. Epub 2014 Jan 24.
6
Divergent activation of ventromedial and ventrolateral dopamine systems in animal models of amphetamine sensitization and schizophrenia.在安非他命敏化和精神分裂症的动物模型中,腹内侧和腹外侧多巴胺系统的激活分歧。
Int J Neuropsychopharmacol. 2012 Feb;15(1):69-76. doi: 10.1017/S1461145711000113. Epub 2011 Feb 18.
7
A novel α5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia.一种新型的 α5GABA(A)R 阳性变构调节剂可逆转精神分裂症 MAM 模型中多巴胺系统的过度激活。
Neuropsychopharmacology. 2011 Aug;36(9):1903-11. doi: 10.1038/npp.2011.76. Epub 2011 May 11.
8
Peripubertal mGluR2/3 Agonist Treatment Prevents Hippocampal Dysfunction and Dopamine System Hyperactivity in Adulthood in MAM Model of Schizophrenia.青春期 mGluR2/3 激动剂治疗可预防精神分裂症 MAM 模型中年大鼠海马功能障碍和多巴胺系统过度活跃。
Schizophr Bull. 2021 Oct 21;47(6):1806-1814. doi: 10.1093/schbul/sbab047.
9
Insights on current and novel antipsychotic mechanisms from the MAM model of schizophrenia.精神分裂症 MAM 模型对现有和新型抗精神病药物机制的研究进展。
Neuropharmacology. 2020 Feb;163:107632. doi: 10.1016/j.neuropharm.2019.05.009. Epub 2019 May 8.
10
α7 Nicotinic receptor-modulating agents reverse the hyperdopaminergic tone in the MAM model of schizophrenia.α7 烟碱型乙酰胆碱受体调节剂可逆转精神分裂症 MAM 模型中的多巴胺能亢进。
Neuropsychopharmacology. 2018 Jul;43(8):1712-1720. doi: 10.1038/s41386-018-0066-0. Epub 2018 Apr 19.

引用本文的文献

1
Diazepam modulates hippocampal CA1 functional connectivity in people at clinical high-risk for psychosis.地西泮调节临床高风险精神病患者海马CA1区的功能连接。
Psychol Med. 2025 Aug 8;55:e230. doi: 10.1017/S0033291725101268.
2
Intrinsic metabolic and immune impairments in a genetic mouse model of schizophrenia.精神分裂症基因小鼠模型中的内在代谢和免疫损伤
Schizophrenia (Heidelb). 2025 Jul 18;11(1):100. doi: 10.1038/s41537-025-00651-9.
3
Corticolimbic circuitry as a druggable target in schizophrenia spectrum disorders: a narrative review.皮质边缘回路作为精神分裂症谱系障碍的可药物作用靶点:一项叙述性综述。
Transl Psychiatry. 2025 Jan 24;15(1):21. doi: 10.1038/s41398-024-03221-2.
4
The antipsychotic agent sulpiride microinjected into the ventral pallidum restores positive symptom-like habituation disturbance in MAM-E17 schizophrenia model rats.腹侧苍白球内注射抗精神病药物舒必利可恢复 MAM-E17 精神分裂症模型大鼠阳性症状样习惯化障碍。
Sci Rep. 2024 May 29;14(1):12305. doi: 10.1038/s41598-024-63059-y.
5
The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia.兴奋性-抑制性平衡作为开发新型抗精神分裂症药物的靶点。
Biochem Pharmacol. 2024 Oct;228:116298. doi: 10.1016/j.bcp.2024.116298. Epub 2024 May 21.
6
Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosis.地西泮对处于精神病临床高危状态人群海马血流的影响。
Neuropsychopharmacology. 2024 Aug;49(9):1448-1458. doi: 10.1038/s41386-024-01864-9. Epub 2024 Apr 24.
7
Effects of Benzodiazepine Exposure on Real-World Clinical Outcomes in Individuals at Clinical High Risk for Psychosis.苯二氮䓬类药物暴露对临床高风险精神病个体现实世界临床结局的影响。
Schizophr Bull. 2025 Mar 14;51(2):446-457. doi: 10.1093/schbul/sbae036.
8
Aberrant Hippocampal Development in Early-onset Mental Disorders and Promising Interventions: Evidence from a Translational Study.早发性精神障碍中海马发育异常及有前景的干预措施:来自转化研究的证据。
Neurosci Bull. 2024 Jun;40(6):683-694. doi: 10.1007/s12264-023-01162-2. Epub 2023 Dec 23.
9
Sex-dependent emergence of prepubertal social dysfunction and augmented dopamine activity in a neurodevelopmental rodent model relevant for schizophrenia.在一种与精神分裂症相关的神经发育啮齿动物模型中,青春期前社交功能障碍的性别依赖性出现及多巴胺活性增强。
Schizophr Res. 2023 Dec;262:32-39. doi: 10.1016/j.schres.2023.10.036. Epub 2023 Nov 1.
10
Congenital blindness does not protect against a schizophrenia-related phenotype in rodents.先天性失明并不能保护老鼠免受与精神分裂症相关的表型影响。
Schizophr Res. 2023 Aug;258:1-8. doi: 10.1016/j.schres.2023.06.007. Epub 2023 Jun 24.

本文引用的文献

1
Prospective relationship of duration of untreated psychosis to psychopathology and functional outcome over 12 years.前瞻性研究未治疗精神病期与 12 年内精神病理学和功能结果的关系。
Schizophr Res. 2012 Nov;141(2-3):215-21. doi: 10.1016/j.schres.2012.08.013. Epub 2012 Sep 21.
2
Temporal association of stress sensitivity and symptoms in individuals at clinical high risk for psychosis.处于精神病临床高风险个体的应激敏感性与症状的时间关联。
Psychol Med. 2013 Feb;43(2):259-68. doi: 10.1017/S0033291712001262. Epub 2012 Jun 1.
3
Are you or aren't you? Challenges associated with physiologically identifying dopamine neurons.你是不是?与生理识别多巴胺神经元相关的挑战。
Trends Neurosci. 2012 Jul;35(7):422-30. doi: 10.1016/j.tins.2012.02.003. Epub 2012 Mar 28.
4
Stress and the prodromal phase of psychosis.压力与精神病前驱期。
Curr Pharm Des. 2012;18(4):527-33. doi: 10.2174/138161212799316280.
5
HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia.青少年精神分裂症临床高危人群的 HPA 轴功能与症状。
Schizophr Res. 2012 Mar;135(1-3):170-4. doi: 10.1016/j.schres.2011.11.035. Epub 2012 Jan 9.
6
Effects of risperidone treatment in adolescence on hippocampal neurogenesis, parvalbumin expression, and vascularization following prenatal immune activation in rats.孕期免疫激活后,利培酮治疗对青春期大鼠海马神经发生、钙结合蛋白表达和血管生成的影响。
Brain Behav Immun. 2012 Feb;26(2):353-63. doi: 10.1016/j.bbi.2011.11.004. Epub 2011 Nov 30.
7
Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia.精神分裂症中的皮质苍白球中间神经元与认知功能障碍。
Trends Neurosci. 2012 Jan;35(1):57-67. doi: 10.1016/j.tins.2011.10.004. Epub 2011 Dec 6.
8
Pituitary volume, stress reactivity and genetic risk for psychotic disorder.垂体体积、应激反应与精神障碍的遗传风险。
Psychol Med. 2012 Jul;42(7):1523-33. doi: 10.1017/S0033291711002728. Epub 2011 Dec 1.
9
Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study.首发精神病前的多巴胺合成能力:一项前瞻性[18F]-DOPA PET 成像研究。
Am J Psychiatry. 2011 Dec;168(12):1311-7. doi: 10.1176/appi.ajp.2011.11010160. Epub 2011 Jul 18.
10
Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume.压力和炎症会降低首发精神病患者脑源性神经营养因子的表达:导致海马体体积减小的一种途径。
J Clin Psychiatry. 2011 Dec;72(12):1677-1684. doi: 10.4088/JCP.10m06745. Epub 2011 May 18.